Transient neurological deficits secondary to saccular vertebrobasilar aneurysms. Report of two cases

Aneurysms have rarely been implicated as a possible cause of transient neurological deficits, and most reports of this phenomenon describe aneurysms in the anterior circulation. There is only one previous report of a saccular posterior circulation aneurysm associated with transient ischemic attacks. The authors document two cases of giant saccular vertebrobasilar artery aneurysms associated with transient neurological deficits.     

Transferrin secretion in response to different modes of FSH stimulation and cycloheximide in superfused Sertoli cell cultures

The influence of different modes of FSH stimulation and cycloheximide on transferrin secretion by rat Sertoli cells was investigated using a superfusion culture system. Sertoli cells from 18-day-old rats were cultured in serum-free medium on Matrigel-covered slides first in static conditions for 19 hours, and then superfused at a flow rate of 2.5 ml/hour. After an equilibration period of 48 hours to establish the basal rate of transferrin secretion, the cultures were exposed to various modes of FSH stimulation. Sertoli cells stimulated intermittently (20 min/2 hours) up to 22 hours responded to each consecutive FSH pulse with a rapid increase of transferrin secretion followed by a decline toward basal values. Continuous 22-hour exposure to FSH elicited an immediate increase followed by irregular fluctuations and a transient decline towards the baseline. With either mode of FSH stimulation, there was a secondary prolonged increase in transferrin secretion. Although cultures stimulated intermittently or continuously during the entire experimental period (22 hours) secreted similar cumulative amounts of transferrin (10.8 +/- 0.5 micrograms and 11.1 +/- 0.8 micrograms, respectively), there was a direct correlation between the secreted amount of transferrin and the duration of FSH exposure up to 8 hours. Addition of cycloheximide decreased both basal and FSH-stimulated transferrin secretion. However, even when cycloheximide was added 1 hour before FSH, an early secretory peak in response to FSH was still observed.(ABSTRACT TRUNCATED AT 250 WORDS)     

Follicle stimulating hormone binding inhibiting activity and inhibin properties of human ovarian cystic and porcine follicular fluid

Ovarian cystic fluid was obtained from 13 regularly cycling women with the operative diagnosis of ovarian serous (n = 6), mucinous cystadenomas (n = 3) and simple follicular cysts (n = 4). The effects of the fluids, after steroid extraction with charcoal treatment, on the binding of follicle stimulating hormone (FSH) to rat testicular homogenates and on the in vitro secretion of FSH and luteinizing hormone (LH) by rat pituitary cell preparations were studied. Similar studies were conducted simultaneously with steroid-free porcine follicular fluid (pFF). Human ovarian cystic fluids produced a marked inhibition of FSH-binding activity in the absence of an effect on FSH or LH secretion. In contrast, pFF exhibited both FSH-binding inhibitory (FSH-BI) and inhibin activities. Furthermore, heating did not alter the FSH-BI activity nor the inhibin properties of steroid-free human ovarian cystic fluids nor porcine follicular fluid.     

T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery

CCR5 is the chemokine co-receptor for R5-tropic human immunodeficiency virus type 1 (HIV-1) isolates most often associated with primary infection. We have developed an HIV-1 self-inactivating vector, CAD-R5, containing a CCR5 single-chain antibody (intrabody) gene, which when expressed in T-cell lines and primary CD4+ T cells disrupts CCR5 cell surface expression and provides protection from R5-tropic isolate exposure. Furthermore, CAD-R5 intrabody expression in primary CD4+ T cells supports significant growth and enrichment over time during HIV-1-pulsed dendritic cell-T-cell interactions. These results indicate that CCR5 intrabody-expressing CD4+ T cells are refractory against this highly efficient primary route of infection. CD34+ cells transduced with the CAD-R5 vector gave rise to CD4+ and CD8+ thymocytes in non-obese diabetic (NOD)/ severely combined-immunodeficient (SCID)-human thymus/liver (hu thy/liv) mice, suggesting that CCR5 intrabody expression can be maintained throughout differentiation without obvious cellular effects. CD4+ T cells isolated from NOD/SCID-hu thy/liv mice were resistant to R5-tropic HIV-1 challenge demonstrating the maintenance of protection. Our findings demonstrate delivery of anti-HIV-1 activity through CCR5 intrabodies in primary CD4+ T cells and CD34+ cell-derived T-cell progeny. Thus, gene delivery strategies that provide a selective survival and growth advantage for T effector cells may provide a therapeutic benefit for HIV-1-infected individuals who have failed conventional therapies.     

Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: importance for allergenic activity

BACKGROUND: The major timothy grass pollen allergen Phl p 1 is one of the most potent and frequently recognized environmental allergens. OBJECTIVE: We sought to study at a molecular and structural level the IgE recognition of Phl p 1 and its relation to allergenic activity. METHODS: Monoclonal human IgE antibody fragments specific for Phl p 1 and group 1 allergens from various grasses were isolated from a combinatorial library made of lymphocytes from patients with grass pollen allergy. Recombinant Phl p 1 fragments and the 3-dimensional structure of Phl p 1 were used to localize the major binding site for the IgE antibodies. A rPhl p 1 fragment containing this binding site was expressed in Escherichia coli, purified, and tested for IgE reactivity and allergenic activity with sera and basophils from patients with grass pollen allergy. RESULTS: Monoclonal antibodies, as well as polyclonal serum IgE, from patients with grass pollen allergy defined a C-terminal fragment of Phl p 1 that represents a sterically oriented portion on the Phl p 1 structure. This Phl p 1 portion bound most of the allergen-specific IgE antibodies and contained the majority of the allergenic activity of Phl p 1. CONCLUSION: IgE recognition of spatially clustered epitopes on allergens might be a general factor determining their allergenic activity. CLINICAL IMPLICATIONS: Geographic distribution of IgE epitopes on an allergen might influence its allergenic activity and hence explain discrepancies between diagnostic test results based on IgE serology and provocation testing. It might also form a basis for the development of low allergenic vaccines.